INTRODUCTION
Subacute granulomatous thyroiditis(SGT) is also known as de Quervain' s thyroiditis, and this malady has an unknown cause, but is thought to be a postviral syndrome. 1, 2 It typically presents in middle aged women who complain of pain and tenderness in the area of the thyroid gland, along with malaise and fever.
The erythrocyte sedimentation rate(ESR) of SGT may be higher than that in any other form of thyroiditis. 3 The thyroid generally shows symmetrical or asymmetrical diffuse enlargement without well-defined nodules.
SGT is usually diagnosed clinically without performing fine-needle aspiration(FNA). Consequently, any cyto- Although subacute granulomatous thyroiditis(SGT) is usually diagnosed clinically, papillary carcinoma or other thyroid conditions must be considered in the differential diagnosis. We retrospectively reviewed the clinical and fine-needle aspiration(FNA) cytologic findings seen in 10 SGT cases to decide what are the most reliable cytologic findings and the most helpful molecular tools for reaching a confident cytologic diagnosis. The most representative smear slides were retrieved to perform immunocytochemistry for cytokeratin19(CK19) and Ret protein.
아급성 육아종성 갑상샘염의 세침흡인 세포소견
Five papillary carcinomas(PTCs) were included as controls. The constant and typical cytologic findings of SGT were multinucleated giant cells(MGCs) (100%), epithelioid granulomas(90%), an inflammatory dirty background(90%) and plump transformed follicular cells(80%) without fire-flare cells, oncocytic cells or transformed lymphocytes. The immunoreactivities for CK19(37.5%) and Ret(10%) of the follicular cells of SGT were less than those(CK19 and Ret:100%) of PTC. CK19 immunoreactivity of the MGCs was seen in only one case of PTC. There was no significant difference between CK19 and Ret immunocytochemical staining for the MGCs of both SGT and PTC. The results of this study demonstrate that the cytological diagnosis of SGT can be improved by employing a combination of the typical and constant diagnostic cytological features and immunocytochemical results. 1, [4] [5] [6] In the early phase of SGT, the typical cytologic findings may be lacking and atypical follicular cells may suggest malignancy. 7 Malignant thyroid lesions can recently be easily diagnosed by immunohistochemical staining in conjunction with using the known molecular markers. 8 To the best of our knowledge, there have been no studies that have examined the expression of molecular markers or immunohistochemical staining of atypical cells for making the differential diagnosis of SGT from malignancy. 9 This study focused on demonstrating the cytologic features and molecular findings of SGT to discriminate it from thyroid malignancy. On retrospective gray-scale ultrasound(US), only three patients revealed enlargements of the glands (more than 1.8 cm in the AP diameter). All of the patients had focal ill-defined hypo echoic areas and three of them were suspicious for malignancy. The flow on color Doppler US was not increased. Eight patients were treated with steroid and then one of them experienced disappearance of the focal lesion and the focal lesions of the other five patients were improved (Table 1) .
MATERIALS AND METHODS

Cytologic Findings(Table 2)
Eighty percent of the subjects revealed plump transformed follicular cells. Ninety percent of the cases showed epithelioid granulomas and an inflammatory dirty background. All the subjects had MGCs (Table 2) . Therefore, the most constant cytologic features of SGT were epithelioid granulomas, MGCs and an inflammatory dirty background with plump transformed follicular cells (Fig. 1 ).
There were hyertrophic follicular cells in 5 cases (50%) out of 10 SGTs, transformed lymphocytes in 3 cases(30%) out of 10 SGTs, fire-flare cells in 1 case (10%) out of 10 SGTs and oncocytic cells in 1 (10%) out Focal ill-defined hypo echoic areas 10 0
Suspicious thyroid carcinoma 3 7
Increase of flow on color Doppler US 0 10
After the steroid therapy, follow-up US(n=8)
Disappearance or 1
Improvement of the lesions 5 2 
Immunocytochemical stainning results (Table 3)
The CK19 and Ret immunoreactivity in the follicular cells revealed that 37.5% of the SGTs were positive for CK19 and 10% of the SGTs were positive for Ret. In contrast to the SGT results, the CK19 and Ret immunoreactivities in the follicular cells of the PTC were all positive (100%). These results were statistically significant (CK19; p=0.02, Ret; p=0.002) (Fig. 2) . There was no SGT case that its follicular cells positively stained with both markers at the same time.
The CK19 and Ret immunoreactivity in the MGCs revealed that none of the cases of SGT was positive for A B C D p=0.333, Ret; p=0.748) (Fig. 3) .
DISCUSSION
These results suggest that immuhocytochemistry will help physicians make the differential diagnosis of SGT from thyroid malignancy. The results of CK19 and Ret in the follicular cells revealed that SGT expressed less of these proteins than did PTC. These differences were statistically significant(CK19; p=0.02, Ret; p=0.002). To diagnosis thyroid malignancy in a surgical specimen, several immunohistochemical markers such as galectin-3, HBME-1 or CK19 have been used and investigated. 8, 11, 12 Therefore, CK19 has also been considered by many investigators to be a useful ancillary tool for making the cytological diagnosis of papillary carcinoma, and especially in the cytologically indeterminate cases. [13] [14] [15] The sensitivity and specificity using CK19 as a single marker were as high as 92% and 97%, respectively. 15 A combination of markers, including CK19 and galectin-3, was reported to reach 100% for both the specificity and sensitivity during the management of thyroid lesions that had a cytologic diagnosis of follicular oncocytic tumor. 13 RET/PTC oncogene immunostaining has been reported to be an additional useful including CK19, galectin-3, and HBME-1, in the assessment of thyroid specimens and aspirates. 16, 17 However, even for the surgical specimen, there has not been any reports concerned with the ancillary tools to differentiate SGT from thyroid malignancy. The cytologic literature on SGT is relatively rare, but the cytologic features of SGT has been well described. 1, [4] [5] [6] 10, 21 One report summarized the key cytologic features of SGT with performing Giemsa staining. 10 and after that, another report has been published that used Papanicolou stain. 21 The aspirate of SGT usually dis- Our study was performed with Papanicolou stain and we were able to compare the reported cytologic features. 10, 21 with those of our cases. Our cytologic results
were consistent with these previous reported descriptions. 10, 21 In summary, the constant and typical cytologic fea- 
